Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - DEPRECIATION & AMORTIZATION
Depreciation & Amortization CHRS - Coherus BioSciences, Inc.
3.79 M
LAST VALUE
4.76%
2 YEAR CAGR
3.22%
5 YEAR CAGR
25.09%
10 YEAR CAGR